BS: Conceptualization, Data curation, Writing review & editing
All pricing is subject to change based on supply costs, formulation updates, and program modifications
The authors emphasize that interpreting preclinical tumor progression data requires caution, as mechanisms affecting incidence may not accurately predict tumor behavior once established
(Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the first quarter ended March 31, 2026, and provided an update on its clinical pipeline and other corporate developments
It is simply financially inaccessible, Bertel says
Excess sugar, or glucose, in the blood is a risk factor for both Parkinsons and Alzheimers, he says, so controlling glucose seems like that would be beneficial. Animal studies, anecdotal evidence and real-world data have hinted that the drugs might benefit people with cognitive disorders